On behalf of the Canadian Heart Rhythm Society Device Advisory Committee, please find attached the Canadian Guidance for the 2025 Boston Scientific RELIANCE ePTFE ICD lead advisory.

Dilawri Foundation makes historic $60 million gift to revolutionize heart care, positioning Vancouver as global leader in heart care www.vchri.ca/news-release...

NEW EPISODE OF THE LEAD! 🎙️ Host: Prashanthan Sanders, MBBS, PhD, FHRS 🎤 Guests: Jason G. Andrade, MD, FHRS and Melanie Gunawardene, MD Listen on your preferred podcast platform ➡️http://bit.ly/48bpxNn

If you’re free come learn how AI can enable clinical trials by providing expert adjudication of arrhythmia outcomes E.g. 1 year of follow-up in CIRCA-DOSE generated 32000 arrhythmia events needing 80k adjudications, which is labour intensive. AI is poised to be transformative

It’s amazing to see consistent information across populations Recapitulating data from CIRCA-DOSE the recent Advantage AF showed AF burden <0.1% & AF episodes less <1h on follow-up had HCU comparable to no AF Same threshold paroxysmal and Persistent AF shorturl.at/gBxXb

It’s been a while since I had to respond to an inflight medical emergency. The personnel, and equipment, on this @aircanada flight were exemplary. I’m grateful for the help they provided and how professional and attentive they were during a difficult situation.

And with that my time at #EHRA2025 and the Ablation innovation summit comes to a close. Congratulations to the organisers for curating another amazing meeting, and for facilitating such a wonderful knowledge exchange

Never been to a conference that invites you to eat the coffee cup… #EHRA2025

Continuing the conversation about AF burden - check out the Top Stories in Electrophysiology www.sciencedirect.com/science/arti...

We are incredibly grateful to the partners and donors who help support our heart rhythm program. While medically necessary hospital & physician services are universal, and funded provincially, we rely on donors to support capital investment @VGHFdn www.theglobeandmail.com/business/art...

New #HeartSounds podcast for Feb 2025 talks #GLP1, #AEDs in schools, PAD pain, wildfires, & sexual minorities. Thanks Nancy Sweitzer, Jonathan Kim, @drjasonandrade.bsky.social, Kim Smolderen, @garimasharmamd.bsky.social, and Mark Miller for your insights! tctmd.com/audio/top-ca...

AEDs, Like Fire Extinguishers, Should Be in Every School, Say Experts

A brief thread on how the new post AF Ablation blanking period impacts clinical outcomes and AF burden from our recent publication in Circulation: A&E www.ahajournals.org/doi/full/10....

I’m happy to share that DRAI Martini is now available online in Nature Medicine Artificial intelligence #AI out-performed trained technologists for direct-to-physician reporting of AECG - less missed diagnoses, better sensitivity, better NPV. www.nature.com/articles/s41...

Atrial Fibrillation is a chronic and progressive disease, with progression being associated with worse clinical outcomes. www.heartrhythmjournal.com/article/S154...

Further to the previous post - @shirleybond has pushed the issue of public access defibrillators, with only BCcand Manitoba having supporting legislation, but a 3 site pilot coming online by 2026 is way to slow for such an important issue

This is an important initiative and definitely something @BCGovnews & @lisabeare should implement

Crash risk following ICD implant. While legal restriction following implant introduces a « what if » it’s reassuring that crash rates among ICD recipients never exceeded those among controls in any tested interval in the first year after ICD implantation heart.bmj.com/content/110/...

We had a great weekend in Washington at the TransformAf meeting followed by the Cardiovascular Clinical Trialists Forum. The former presenting the landscape of pulsed field ablation, from lesion science to clinical efficacy. The latter bringing together clinical trialists across 🫀, 🧠, 💉, etc

Celebrating John A. Cairns on his appointment to the Order of Canada. In addition to major international contributions to cardiology, notably demonstrating the benefits of aspirin for patients with unstable angina, John has been a support and mentor to many within and outside our division.

There’s something special about terminating AVNRT with ablation. Personally I like to target the slow pathway in tachycardia (1), watching it slow (2) with early temperature drop then blocks in slow pathway (3).

These two trials are "steps forward," @drjasonandrade.bsky.social says. "They’re helpful in improving our knowledge of the treatment of persistent A-fib, which is definitely an area where we need to improve our knowledge." @tctmd.bsky.social @ahascience.bsky.social www.tctmd.com/news/two-tri...

Would you call this atrial fibrillation? What’s the prognostic significance of this finding?

Trying to recreate our #EPeeps here! Adding some great educators who have made the leap: @narrowqrs.bsky.social @mgkatz036.bsky.social @jeffreyvinocur.bsky.social @drjasonandrade.bsky.social @basteinberg.bsky.social @tinabaykaner.bsky.social and more…

Congrats to Rajeev Pathak, @prashsanders.bsky.social and team on the ARREST-AF RCT. Incredibly informative data - adjective comprehensive risk factor optimisation significantly improved post ablation AF freedom. We now have RCT evidence supporting RFM as a foundation and pillar of AF management.

Fantastic presentation from Mina Chung on the results of the TRIM-AF study. RFM +/- Metformin had benefit in symptoms but no benefit on AF burden.

Congratulations to Lena Rivard on the @ahascience.bsky.social presentation of the BRAIN-AF study results. Major observation is that cognitive decline occurs in many « low risk » AF patients. Unfortunately, Rivaroxaban 15 mg daily did not impact this risk in this double-dummy RCT.

Congratulations to @omwazni and the OPTION study team on the @ahascience.bsky.social presentation and publication of the OPTION trial. Similar low rates of stroke post ablation (no difference with laao vs OAC) with no significant 23% lower rate of major bleeding. www.nejm.org/doi/full/10....

Congratulations to @johnlsapp on the presentation and publication of VANISH-2. First line VT ablation is associated with significant reduction in composite of death, VT, storm for patients with ischemic cardiomyopathy. www.nejm.org/doi/full/10....

An #AHA24 Pre-LBCT session 2 selfie with two PIs - Léna Rivard from @ICMtl presenting the results from BRAIN-AF, and - John Sapp from @DalhousieU presenting the results from VANISH-2

Please join us in Main Event II at 15:15 for « Fellowship of the Ring: Atrial Fibrillation & Heart Failure, a Collaborative Journey Through the New Middle Earth »

In honour of Remembrance Day, where we reflect on the “men and women who have served, and continue to serve our country during times of war, conflict and peace" I thought I would reflect on my Family members who have served during the First and Second World Wars.

It’s been a privilege to have John Mandrola join us at UBC to present grand rounds. An insightful reflection on the evidence underlying the decisions we make as clinicians.

I had a fantastic time in Istanbul at the Interactive & Intensive ElectroPhysiology International. The national and international faculty was stellar and I really learned a lot. Congratulations and thanks to Prof Otto and Tolga Aksu for the invite.

It was a privilege to participate in the lead sessions for #BostonAF day two speaking about Ablation and AF progression alongside important talks from @Phiso_de S. Willems D. Packer F. Marchilinski